Home > Name List By n > N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1- yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]ami... Spain

CAS No 65807-02-5 , N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-
yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-
oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]
amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-
oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-
imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide Search by region : Spain

  • Name: N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-
    yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-
    oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]
    amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-
    oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-
    imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
  • Synonyms: ICI 118630; Goserelina [Spanish]; Gosereline [French];N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-
    yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-
    oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]
    amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-
    oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-
    imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide; Goserelinum [Latin]; 65807-02-5;Decapeptide I;
  • CAS Registry Number:
  • Flash Point: °C
  • Boiling Point: °Cat760mmHg
  • Density: 1.5 g/cm3
  • Refractive index: 1.692
  • Safety Statements: S22;S24/25;
  • Flash Point: °C
  • Molecular Weight: 1269.41046
  • InchiKey: BLCLNMBMMGCOAS-UHFFFAOYSA-N
  • InChI: InChI=1S/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56
    (89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,
    4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42
    (24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-
    48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,
    8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,
    86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,
    90)
  • Molecular Formula: C59H84N18O14
  • Molecular Structure:CAS No:65807-02-5 N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-<br />yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-<br />oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]<br />amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-<br />oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-<br />imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

Related products

Select to

65807-02-5 GOSERELIN

  • Spain BCN PEPTIDES S.A. [Manufacturer]
  • Tel: +34 93 819 13 99
  • Fax: +34 93 638 93 93
  • Address: BCN Peptides S.A.
    Poligon Industrial Els Vinyets-Els Fogars II
    08777 Sant Quint? de Mediona
    Barcelona - Spain null,nullSpain
Contact Supplier

Select to

References of N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-
yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-
oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]
amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-
oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-
imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
Title: Goserelin
CAS Registry Number: 65807-02-5
CAS Name: 6-[O-(1,1-Dimethylethyl)-D-serine]-10-deglycinamideluteinizing hormone-releasing factor (pig) 2-(aminocarbonyl)hydrazide
Synonyms: D-Ser(But)6Azgly10-gonadorelin; D-Ser(But)6Azgly10-luliberin
Manufacturers' Codes: ICI-118630
Molecular Formula: C59H84N18O14
Molecular Weight: 1269.41
Percent Composition: C 55.82%, H 6.67%, N 19.86%, O 17.65%
Literature References: Synthetic peptide agonist analog of LH-RH, q.v. Prepn: A. S. Dutta et al., DE 2720245; eidem, US 4100274 (1977, 1978 both to I.C.I.); eidem, J. Med. Chem. 21, 1018 (1978). Radioimmunoassay in serum: R. N. Clayton et al., Clin. Endocrinol. 22, 453 (1985). Endocrine effects in women: C. P. West, D. T. Baird, ibid. 26, 213 (1987). Review of pharmacokinetics and therapeutic efficacy in sex hormone related disorders: P. Chrisp, K. L. Goa, Drugs 41, 254-288 (1991). Clinical trial in treatment of uterine fibroids: J. Gerris et al., Horm. Res. 45, 279 (1996); in prostate cancer: M. Bolla et al., N. Engl. J. Med. 337, 295 (1997).
 
Derivative Type: Acetate
Trademarks: Zoladex (AstraZeneca)
Literature References: C59H84N18O14.xC2H4O2, where x = 1 to 2.4.
Properties: Off-white powder. Freely sol in acetic acid; sol in water, 0.1M HCl, 0.1M NaCl, DMF, DMSO. Insol in acetone, chloroform, ether.
 
Therap-Cat: Antineoplastic (hormonal).
Keywords: Antineoplastic (Hormonal); LH-RH Analogs; LH-RH Agonist.